Atria Investments Inc Has $589,000 Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Atria Investments Inc increased its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 16.5% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 31,663 shares of the real estate investment trust’s stock after acquiring an additional 4,474 shares during the quarter. Atria Investments Inc’s holdings in Sabra Health Care REIT were worth $589,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in SBRA. Point72 Asset Management L.P. raised its stake in Sabra Health Care REIT by 152.7% during the 2nd quarter. Point72 Asset Management L.P. now owns 1,732,274 shares of the real estate investment trust’s stock worth $26,677,000 after buying an additional 1,046,748 shares during the period. Millennium Management LLC acquired a new stake in Sabra Health Care REIT during the 2nd quarter worth $12,972,000. Vanguard Group Inc. raised its stake in Sabra Health Care REIT by 2.5% during the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust’s stock worth $516,545,000 after buying an additional 838,654 shares during the period. APG Asset Management US Inc. raised its stake in shares of Sabra Health Care REIT by 28.9% in the 2nd quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust’s stock valued at $39,495,000 after purchasing an additional 575,000 shares during the period. Finally, Renaissance Technologies LLC raised its stake in shares of Sabra Health Care REIT by 77.0% in the 2nd quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust’s stock valued at $19,824,000 after purchasing an additional 559,800 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

Shares of NASDAQ SBRA opened at $18.57 on Wednesday. The stock has a market capitalization of $4.39 billion, a price-to-earnings ratio of 45.29, a PEG ratio of 2.28 and a beta of 1.25. The business has a 50-day moving average of $18.63 and a 200-day moving average of $16.63. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. Sabra Health Care REIT, Inc. has a fifty-two week low of $12.83 and a fifty-two week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). The company had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter in the previous year, the business earned $0.34 EPS. As a group, sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.46%. The ex-dividend date is Friday, November 15th. Sabra Health Care REIT’s payout ratio is currently 292.69%.

Analyst Ratings Changes

Several analysts have issued reports on the company. Truist Financial lifted their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Scotiabank lifted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. Finally, Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lifted their price target for the company from $17.00 to $20.00 in a research note on Friday, September 13th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Sabra Health Care REIT has a consensus rating of “Moderate Buy” and a consensus target price of $18.71.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.